 |
PDBsum entry 6f0x
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
308 a.a.
|
 |
|
|
|
|
|
|
|
398 a.a.
|
 |
|
|
|
|
|
|
|
282 a.a.
|
 |
|
|
|
|
|
|
|
194 a.a.
|
 |
|
|
|
|
|
|
|
204 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Cell cycle
|
 |
|
Title:
|
 |
Cryo-em structure of trip13 in complex with atp gamma s, p31comet, c- mad2 and cdc20
|
|
Structure:
|
 |
Pachytene checkpoint protein 2 homolog. Chain: a, b, c, d, e, f. Synonym: human papillomavirus type 16 e1 protein-binding protein, hpv16 e1 protein-binding protein,thyroid hormone receptor interactor 13,thyroid receptor-interacting protein 13,trip-13. Engineered: yes. Mad2l1-binding protein. Chain: p. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: trip13, pch2. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: cdc20. Expressed in: trichoplusia ni. Expression_system_taxid: 7111.
|
|
Authors:
|
 |
C.Alfieri,L.Chang,D.Barford
|
|
Key ref:
|
 |
C.Alfieri
et al.
(2018).
Mechanism for remodelling of the cell cycle checkpoint protein MAD2 by the ATPase TRIP13.
Nature,
559,
274-278.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Nov-17
|
Release date:
|
02-May-18
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q15645
(PCH2_HUMAN) -
Pachytene checkpoint protein 2 homolog from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
432 a.a.
308 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q15645
(PCH2_HUMAN) -
Pachytene checkpoint protein 2 homolog from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
432 a.a.
398 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
Q15645
(PCH2_HUMAN) -
Pachytene checkpoint protein 2 homolog from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
432 a.a.
282 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
559:274-278
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanism for remodelling of the cell cycle checkpoint protein MAD2 by the ATPase TRIP13.
|
|
C.Alfieri,
L.Chang,
D.Barford.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The maintenance of genome stability during mitosis is coordinated by the spindle
assembly checkpoint (SAC) through its effector the mitotic checkpoint complex
(MCC), an inhibitor of the anaphase-promoting complex (APC/C, also known as the
cyclosome)1,2. Unattached kinetochores control MCC assembly by
catalysing a change in the topology of the β-sheet of MAD2 (an MCC subunit),
thereby generating the active closed MAD2 (C-MAD2) conformer3-5.
Disassembly of free MCC, which is required for SAC inactivation and chromosome
segregation, is an ATP-dependent process driven by the AAA+ ATPase TRIP13. In
combination with p31comet, an SAC antagonist6, TRIP13
remodels C-MAD2 into inactive open MAD2 (O-MAD2)7-10. Here, we
present a mechanism that explains how TRIP13-p31comet disassembles
the MCC. Cryo-electron microscopy structures of the
TRIP13-p31comet-C-MAD2-CDC20 complex reveal that p31comet
recruits C-MAD2 to a defined site on the TRIP13 hexameric ring, positioning the
N terminus of C-MAD2 (MAD2NT) to insert into the axial pore of TRIP13
and distorting the TRIP13 ring to initiate remodelling. Molecular modelling
suggests that by gripping MAD2NT within its axial pore, TRIP13
couples sequential ATP-driven translocation of its hexameric ring along
MAD2NT to push upwards on, and simultaneously rotate, the globular
domains of the p31comet-C-MAD2 complex. This unwinds a region of the
αA helix of C-MAD2 that is required to stabilize the C-MAD2 β-sheet, thus
destabilizing C-MAD2 in favour of O-MAD2 and dissociating MAD2 from
p31comet. Our study provides insights into how specific substrates
are recruited to AAA+ ATPases through adaptor proteins and suggests a model of
how translocation through the axial pore of AAA+ ATPases is coupled to protein
remodelling.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |